Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed)
Key Information
Due Date: January 7, 2025
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: $581,371
Funding Type: Grant, Government
Match Required: No
Status: Posted
Contact Info:
OERWebmaster03@od.nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
This research should provide considerable justification for further phases of therapeutics discovery and development concerning health-relatable outcomes. These outcomes must be relevant to the NIDDK and include, but are not limited to, areas like obesity, diabetes, endocrinology, metabolism, digestive diseases, liver diseases, nutrition, and kidney and urological diseases, and hematology.
Additional information about the programmatic areas at NIDDK can be found on their website. Applicants are strongly advised to discuss their research priorities with the Scientific Contact at NIDDK to enhance their applications' relevance and potential for success. Clinical trials are not permitted under this particular grant opportunity.
Key Dates
Open Date: February 4, 2022
Application Due Date: January 7, 2025
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses